{
    "clinical_study": {
        "@rank": "97293", 
        "arm_group": [
            {
                "arm_group_label": "slow fluid rate", 
                "arm_group_type": "Active Comparator", 
                "description": "bolus 10 ml/kg of NS followed by 1.25 times maintenance rate"
            }, 
            {
                "arm_group_label": "Fast fluid rate", 
                "arm_group_type": "Active Comparator", 
                "description": "bolus 20 ml/kg of NS followed by 1.5 times maintenance rate"
            }
        ], 
        "brief_summary": {
            "textblock": "Randomized trial to determine if the volume of fluid administration in pediatric patients\n      with DKA impacts the rate of normalization of serum bicarbonate, pH as well as the length of\n      treatment"
        }, 
        "brief_title": "Fluid Resuscitation for Pediatric Diabetic Ketoacidosis", 
        "completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetic Ketoacidosis", 
                "Ketosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "A randomized trial of two initial volumes of IVF and subsequent administration rates. Group\n      I received 10 mL/kg of NS intravenous bolus over the first hour followed by \u00be NS with\n      potassium replacement at 1.25 times maintenance and Group II received 20 mL/kg of NS\n      intravenous bolus over the first hour followed by \u00be NS with potassium replacement at 1.5\n      times maintenance. The specific variables measured included demographics (age, gender, and\n      race/ethnicity) and routine laboratory values (pH, pCO2, plasma glucose, electrolytes,\n      bicarbonate, sodium, chloride, BUN. Length of treatment was defined as a time of the\n      hospital stay after the start of IVF infusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1 day to 18 years of age\n\n          -  type 1 diabetes\n\n          -  presence of DKA, as defined by glucose >250 mg/dl, accumulation of ketone bodies in\n             the blood, and metabolic acidosis (venous pH < 7.30 or serum bicarbonate < 15\n             mmol/L.)\n\n        Exclusion Criteria:\n\n          -  requirement for additional fluid resuscitation for hemodynamic instability\n\n          -  weight greater than 70 kilograms"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701557", 
            "org_study_id": "06-0846"
        }, 
        "intervention": [
            {
                "arm_group_label": "slow fluid rate", 
                "description": "10 mL/kg of NS intravenous bolus over the first hour followed by \u00be NS with potassium replacement at 1.25 times maintenance", 
                "intervention_name": "slow fluid rate", 
                "intervention_type": "Other", 
                "other_name": "normal saline"
            }, 
            {
                "arm_group_label": "Fast fluid rate", 
                "description": "20 mL/kg of NS intravenous bolus over the first hour followed by \u00be NS with potassium replacement at 1.5 times maintenance", 
                "intervention_name": "fast fluid rate", 
                "intervention_type": "Other", 
                "other_name": "normal saline"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Ketoacidosis Fluids", 
        "lastchanged_date": "October 3, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80045"
                }, 
                "name": "the Childrens Hospital Colorado"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Fluid Resuscitation for Pediatric Diabetic Ketoacidosis", 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Arleta Rewers, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Laboratory parameters were measured hourly for the first 4 hours, and every 2 to3 hours thereafter until acid-base normalization (pH was above 7.3 or the HCO3 was above 15 mmol/L)", 
            "measure": "time to normalization of bicarbonate and pH", 
            "safety_issue": "No", 
            "time_frame": "start of treatment until resolution of DKA an expected average of 12 to 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701557"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Length of treatment was defined as a time of the hospital stay after the start of IVF infusion", 
            "measure": "the length of treatment", 
            "safety_issue": "No", 
            "time_frame": "discharge from the hospital, an expected average of 1-2 days"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}